SIGHT SCIENCES, INC. Proceeds from Issuance of Debt
SIGHT SCIENCES, INC. (SGHT) reported Proceeds from Issuance of Debt of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-24.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfDebt · last filed 2022-03-24
- SIGHT SCIENCES, INC. proceeds from issuance of debt for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- SIGHT SCIENCES, INC. proceeds from issuance of debt for fiscal 2020 was $20.48M.
| Period end | Proceeds from Issuance of Debt 12 month |
|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-03-24 |
| 2020-12-31 | $20.48M 10-K · filed 2022-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |